Newstral
Article
Mmarketwatch.com on 2020-01-22 14:13
Dow getting a 22-point boost from IBM's stock rally, J&J's decline after earnings
Related news
- MDow breaks slightly lower at Friday's open as J&J's stock weighs on blue chipsmarketwatch.com
- MDow opens tentatively higher, but gains limited as IBM's stock sinks after earningsmarketwatch.com
- What To Expect From J&J's Full Year 2015 Earnings Announcement?Forbes
- MHere's how the 'pause' on J&J's COVID-19 shot may affect the company's earningsmarketwatch.com
- BJ&J's Earnings Were Mixed. Why the Stock Is Falling.2 min readbarrons.com
- MDow futures slip as earnings season kicks off, J&J pauses coronavirus vaccine trialmarketwatch.com
- J&J's single-shot vaccine 66% effectivereuters.com
- J&J's 2014 revenue rose, profits soaredPhilly.com
- IBM's Fourth-Quarter Earnings: What to Watchwsj.com
- Patent for J&J's Remicade invalidatedThe Salt Lake Tribune
- MIBM's 4% stock tumble slashes 45 points from the Dowmarketwatch.com
- EU regulator recommends using J&J's one-shot vaccinelasvegassun.com
- J&J's booster shown effective against Covid hospitalizationPOLITICO
- MIBM's stock tumble cuts nearly 30 points from Dow industrialsmarketwatch.com
- What To Make Of J&J's First Xarelto Lawsuit LossForbes
- Video: Cyber bug in J&J's insulin pumpThe Globe and Mail
- EU considers booster doses of J&J's COVID-19 vaccinedailyherald.com
- J&J's single-dose Covid vax gets emergency use nodThe Times of India
- J&J's deceptive marketing fuelled US opioid crisis, court hearsSydney Morning Herald